We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Impact of time to treatment of oseltamivir on influenza hospitalization cost among Korean children.
- Authors
Lim, Jacqueline K; Kilgore, Paul E; Aiello, Allison E; Foxman, Betsy; Letson, G William; Jang, Gi‐Young; Chung, Eunhee; Song, Young‐Hwan; Kim, Yun‐Kyung
- Abstract
Background Although oseltamivir is a common influenza treatment, there is a lack of data on the economic benefits of timely oseltamivir treatment. Methods From February 2004 through June 2007, 116 hospitalized children ≤15 years of age with laboratory-confirmed influenza who received oseltamivir were identified via retrospective medical chart review. Demographic, clinical, and cost data were abstracted and multivariate linear regression was used to assess the association between oseltamivir time to treatment and treatment-related costs among hospitalized children with laboratory-confirmed influenza. Results Overall, 28% ( n = 33) of patients were treated with oseltamivir ≥day 3 of admission. Rapid influenza diagnostic test was used in a significantly lower proportion of patients treated with oseltamivir ≥day 3 of admission compared with those who received oseltamivir earlier. On multivariate linear regression, initiation of oseltamivir ≥day 3 of admission was associated with a 60.84% increase (95% CI: 32.59-95.11) in treatment-related hospital costs, compared with initiation on admission. Conclusion Delayed initiation of oseltamivir was found to be associated with increased treatment-related hospital costs among children hospitalized with laboratory-confirmed influenza.
- Subjects
SOUTH Korea; RESEARCH funding; ACADEMIC medical centers; HOSPITAL care; COST analysis; INFLUENZA; DESCRIPTIVE statistics; OSELTAMIVIR; TREATMENT delay (Medicine); CONFIDENCE intervals; MEDICAL care costs
- Publication
Pediatrics International, 2015, Vol 57, Issue 3, p393
- ISSN
1328-8067
- Publication type
Article
- DOI
10.1111/ped.12526